Revive Therapeutics Ltd.
RVVTF
$0.01
$0.00-9.09%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 97.05% | -1,624.59% | -54.40% | 24.80% | 81.67% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.05% | 8,961.66% | 969.01% | 69.05% | -99.75% |
| Change in Net Operating Assets | -33.64% | -80.30% | 180.49% | 4,016.00% | -92.31% |
| Cash from Operations | -2,304.65% | 91.67% | 66.80% | 54.90% | -70.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -175.34% |
| Cash from Investing | -- | -- | -- | 100.00% | -175.34% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 67.26% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | 156.95% |
| Cash from Financing | 677.54% | -141.28% | -- | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.00% | -265.08% | 95.95% | 57.61% | -81.58% |